Literature DB >> 12970137

Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts.

L E M Willemsen1, M A Koetsier, S J H van Deventer, E A F van Tol.   

Abstract

BACKGROUND: The mucus layer protects the gastrointestinal mucosa from mechanical, chemical, and microbial challenge. Mucin 2 (MUC-2) is the most prominent mucin secreted by intestinal epithelial cells. There is accumulating evidence that subepithelial myofibroblasts regulate intestinal epithelial cell function and are an important source of prostaglandins (PG). PG enhance mucin secretion and are key players in mucoprotection. The role of bacterial fermentation products in these processes deserves further attention. AIMS: We therefore determined whether the effect of short chain fatty acids (SCFA) on MUC-2 expression involves intermediate PG production.
METHODS: Both mono- and cocultures of epithelial cells and myofibroblasts were used to study the effects of SCFA on MUC-2 expression and PG synthesis. Cell culture supernatants were used to determine the role of myofibroblast derived prostaglandins in increasing MUC-2 expression in epithelial cells.
RESULTS: Prostaglandin E(1) (PGE(1)) was found to be far more potent than PGE(2) in stimulating MUC-2 expression. SCFA supported a mucoprotective PG profile, reflected by an increased PGE(1)/PGE(2) ratio in myofibroblast supernatants and increased MUC-2 expression in mono- and cocultures. Incubation with indomethacin revealed the latter to be mediated by PG.
CONCLUSIONS: SCFA can differentially regulate PG production, thus stimulating MUC-2 expression in intestinal epithelial cells. This mechanism involving functional interaction between myofibroblasts and epithelial cells may play an important role in the mucoprotective effect of bacterial fermentation products.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970137      PMCID: PMC1773837          DOI: 10.1136/gut.52.10.1442

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  45 in total

1.  Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis.

Authors:  W Scheppach; H Sommer; T Kirchner; G M Paganelli; P Bartram; S Christl; F Richter; G Dusel; H Kasper
Journal:  Gastroenterology       Date:  1992-07       Impact factor: 22.682

2.  Fibroblasts modulate intestinal secretory responses to inflammatory mediators.

Authors:  H M Berschneider; D W Powell
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

3.  Interleukin-1 is a mucus secretagogue.

Authors:  V L Cohan; A L Scott; C A Dinarello; R A Prendergast
Journal:  Cell Immunol       Date:  1991-09       Impact factor: 4.868

Review 4.  The control and consequences of bacterial fermentation in the human colon.

Authors:  J H Cummings; G T Macfarlane
Journal:  J Appl Bacteriol       Date:  1991-06

5.  Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease.

Authors:  Y R Mahida; K Wu; D P Jewell
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

6.  Epithelial-mesenchymal interactions in intestinal epithelial differentiation.

Authors:  M Kedinger; P Simon-Assmann; F Bouziges; K Haffen
Journal:  Scand J Gastroenterol Suppl       Date:  1988

7.  The effect of 16,16-dimethyl prostaglandin E2 on proliferation of an intestinal goblet cell line and its synthesis and secretion of mucin glycoproteins.

Authors:  T E Phillips; C M Stanley; J Wilson
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1993-06       Impact factor: 4.006

8.  The prevention and healing of acute non-steroidal anti-inflammatory drug-associated gastroduodenal mucosal damage by misoprostol.

Authors:  K D Bardhan; I Bjarnason; D L Scott; W M Griffin; G C Fenn; M J Shield; S V Morant
Journal:  Br J Rheumatol       Date:  1993-11

9.  Multicenter study of the safety/efficacy of misoprostol in the prevention and treatment of NSAID-induced gastroduodenal lesions.

Authors:  I Grazioli; M Avossa; A Bogliolo; M Broggini; A Carcassi; U Carcassi; L Cecconami; G C Ligniere; B Colombo; G Consoli
Journal:  Clin Exp Rheumatol       Date:  1993 May-Jun       Impact factor: 4.473

Review 10.  Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.

Authors:  I Bjarnason; J Hayllar; A J MacPherson; A S Russell
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

View more
  127 in total

1.  Impact of perioperative probiotic treatment for surgical site infections in patients with colorectal cancer.

Authors:  Naoya Aisu; Shu Tanimura; Yuichi Yamashita; Kanefumi Yamashita; Kenji Maki; Yoichiro Yoshida; Takamitsu Sasaki; Shinsuke Takeno; Seiichiro Hoshino
Journal:  Exp Ther Med       Date:  2015-07-15       Impact factor: 2.447

Review 2.  Probiotics and barrier function in colitis.

Authors:  P Gionchetti; K M Lammers; F Rizzello; M Campieri
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

3.  Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy.

Authors:  Hidetoshi Kanazawa; Masato Nagino; Satoshi Kamiya; Shunichiro Komatsu; Toshihiko Mayumi; Kenji Takagi; Takashi Asahara; Koji Nomoto; Ryuichiro Tanaka; Yuji Nimura
Journal:  Langenbecks Arch Surg       Date:  2005-02-12       Impact factor: 3.445

4.  IL-33 Induces Murine Intestinal Goblet Cell Differentiation Indirectly via Innate Lymphoid Cell IL-13 Secretion.

Authors:  Amanda Waddell; Jefferson E Vallance; Amy Hummel; Theresa Alenghat; Michael J Rosen
Journal:  J Immunol       Date:  2018-12-07       Impact factor: 5.422

Review 5.  Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.

Authors:  Roberto Berni Canani; Margherita Di Costanzo; Ludovica Leone; Monica Pedata; Rosaria Meli; Antonio Calignano
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

Review 6.  Prebiotics metabolism by gut-isolated probiotics.

Authors:  Muhamad Hanif Rawi; Siti Aisyah Zaman; Khairul Faizal Pa'ee; Sui Sien Leong; Shahrul Razid Sarbini
Journal:  J Food Sci Technol       Date:  2020-01-20       Impact factor: 2.701

Review 7.  Reevaluating the hype: four bacterial metabolites under scrutiny.

Authors:  E E Fröhlich; R Mayerhofer; P Holzer
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

Review 8.  Gastrointestinal immune and microbiome changes during parenteral nutrition.

Authors:  Joseph F Pierre
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-02-02       Impact factor: 4.052

Review 9.  Microbiota and metabolic diseases.

Authors:  Alessia Pascale; Nicoletta Marchesi; Cristina Marelli; Adriana Coppola; Livio Luzi; Stefano Govoni; Andrea Giustina; Carmine Gazzaruso
Journal:  Endocrine       Date:  2018-05-02       Impact factor: 3.633

10.  Probiotics L. acidophilus and B. clausii Modulate Gut Microbiota in Th1- and Th2-Biased Mice to Ameliorate Salmonella Typhimurium-Induced Diarrhea.

Authors:  Biswaranjan Pradhan; Dipanjan Guha; Aman Kumar Naik; Arka Banerjee; Subodh Tambat; Saurabh Chawla; Shantibhusan Senapati; Palok Aich
Journal:  Probiotics Antimicrob Proteins       Date:  2019-09       Impact factor: 4.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.